OPEN END TURBO OPTIONSSCHEIN SHORT - BECTON DICKINSON AND CO. Stock

Certificat

DE000GZ0G993

Real-time BOERSE MUENCHEN 08:26:50 2024-05-21 am EDT
5.33 EUR 0.00% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - BECTON DICKINSON AND CO.
Current month-4.65%
1 month-5.33%
Date Price Change
24-05-21 5.33 0.00%
24-05-20 5.33 -0.74%
24-05-17 5.37 +1.90%
24-05-16 5.27 +0.76%
24-05-15 5.23 -4.91%

Real-time BOERSE MUENCHEN

Last update May 21, 2024 at 08:26 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer Goldman Sachs
WKN GZ0G99
ISINDE000GZ0G993
Date issued 2022-09-21
Strike 294.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.91
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.08
Lowest since issue 0.81
Spread 0.1
Spread %1.86%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
237.1 USD
Average target price
279 USD
Spread / Average Target
+17.66%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW